4-[(2S)-2-(1-hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylic acid
C20H25F3N2O5 — CID 174506052
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(2S)-2-(1-hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylic acid
4-[(2S)-2-(1-hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylic acid (PubChem CID 174506052) has the molecular formula C20H25F3N2O5 and a molecular weight of 430.42 g/mol. Its IUPAC name is 4-[(2S)-2-(1-hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylic acid.
Molecular Properties
| Compound Name | 4-[(2S)-2-(1-hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylic acid |
|---|---|
| PubChem CID | 174506052 |
| Molecular Formula | C20H25F3N2O5 |
| Molecular Weight | 430.42 g/mol |
| Exact Mass | 430.17 |
| IUPAC Name | 4-[(2S)-2-(1-hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylic acid |
| SMILES | O=C(O)N1CCN(C(=O)[C@@H](c2cccc(OC(F)(F)F)c2)C2(O)CCCCC2)CC1 |
| InChI | InChI=1S/C20H25F3N2O5/c21-20(22,23)30-15-6-4-5-14(13-15)16(19(29)7-2-1-3-8-19)17(26)24-9-11-25(12-10-24)18(27)28/h4-6,13,16,29H,1-3,7-12H2,(H,27,28)/t16-/m1/s1 |
| InChIKey | ZQDWKMBGBWCDQX-MRXNPFEDSA-N |
| XLogP | 3.19 |
| TPSA | 90.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.42 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174506052 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.